Skip to content

A clinical trial to study the effects of two different wavelength of ND:YAG laser in treatment of dark lips

Comparative study of the efficacy of Q-switched double frequency ND:YAG 1064nm laser versus 532nm laser in treatment of lip hyperpigmentation. - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/078784
Enrollment
50
Registered
2024-12-31
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 3- Administration Health Condition 2: L818- Other specified disorders of pigmentation

Interventions

Intervention1: Nd:YAG 532nm: 532nm Nd Yag laser using fluence 2.0J/cm2 with 3mm spot size done every 2weeks interval 3 sessions maximum till clearance of pigmentation Control Intervention1: Nd:YAG 10

Sponsors

Leena raveendra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients suffering from benign lip hyperpigmentation Age > 18years

Exclusion criteria

Exclusion criteria: Pregnant or lactating women Patients having a keloid-forming tendency Smokers Patients using systemic retinoids. Patients who have multiple diffuse hyperpigmented lesions on the lips and/or systemic involvement consisting of lentiginosis syndrome, endocrine and metabolic disorders (e.g., Addison’s disease, Cushing’s disease, hyperthyroidism,), heavy metal toxicities, and HIV infection. Patients who recently underwent lip tattooing or lip augmentation less than 2 years ago. Patients who have history of herpes labialis

Design outcomes

Primary

MeasureTime frame
pigmentation will be assessed with visual analog scaleTimepoint: lip pigmentation at the end of 10weeks

Secondary

MeasureTime frame
pigmentation will be assessed seen for any newer pigmentationTimepoint: lip pigmentation assessed for every 2 weeks

Countries

India

Contacts

Public ContactDr leena R

rajarajeshwari medical college and hospital

cbleena@gmail.com9845103089

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026